Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Dexmedetomidine and Midazolam Premedication in Pediatric Elective Surgery
NCT06979791Phase 2Completed
- Sponsor
- Cairo University
- Start
- Jun 2025
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of dexmedetomidine and midazolam in preoperative anxiety (2 arms), sponsored by Cairo University. Primary endpoint: Mask Acceptance Score at 30 minutes. Started Jun 2025; status: completed.
02
Drugs
dexmedetomidinemidazolam
03
Conditions
preoperative anxiety
Beyond the preview
Go deeper on NCT06979791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06979791.